​

Funding Round

Series A - Linus Biotechnology

Series A - Linus Biotechnology

Investment Firm

Overview

Linus Biotechnology develops a technology platform to improve human health through precision exposome medicine.

Announced Date

Jan 05, 2023

Funding Type

Series A

Highlights

Location

New York, United States, North America

Social

Investor Lead

GreatPoint Ventures

GreatPoint Ventures

GreatPoint Ventures is a early_stage_venture and late_stage_venture and seed and venture firm.

Bow Capital

Bow Capital

Bow Capital is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

5

Investor Name
Participant InvestorNicole Shanahan
Participant InvestorBow Capital
Participant InvestorSanford Robertson
Participant InvestorDivergent Investments
Participant InvestorGreatPoint Ventures

Round Details and Background

Linus Biotechnology raised $16000000 on 2023-01-05 in Series A

Linus Biotechnology develops a technology platform to improve human health through precision exposome medicine.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 21, 2022
Seed Round - Linus Biotechnology
-1.5M
Jan 05, 2023
Series A - Linus Biotechnology
7-16.0M
May 25, 2023
Series B - Linus Biotechnology
-8.0M

Recent Activity

There is no recent news or activity for this profile.